Fora Capital, LLC Meridian Bioscience Inc Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$31.15 - $33.39 $202,848 - $217,435	6,512 New	6,512 $216,000
Q2 2022 Aug 11, 2022	BUY	$23.75 - $31.69 $367,602 - $490,497	15,478 New	15,478 $471,000
Q4 2020 Feb 12, 2021	SELL	$15.73 - $21.66 $65,059 - $89,585	-4,136 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$13.54 - $26.41 $56,001 - $109,231	4,136 New	4,136 $70 Million
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $20,250 - $60,158	-2,583 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $14,387 - $29,704	2,583 New	2,583 $21,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.